•
Mar 31, 2022

Summit Therapeutics Q1 2022 Earnings Report

Total Revenue
$250K
Previous year: $192K
+30.2%
EPS
-$0.22
Previous year: -$0.21
+4.8%
Gross Profit
$250K
Previous year: $192K
+30.2%
Cash and Equivalents
$77.5M
Previous year: $102M
-24.2%
Free Cash Flow
-$19.4M
Previous year: -$20.7M
-6.5%
Total Assets
$116M
Previous year: $141M
-17.3%

Summit Therapeutics

Summit Therapeutics